Supplementary Figure 18. KEAPness and the 29 tumor microenvironment (TIME)-related signatures in the pooled SU2C/OAK/POPLAR cohort (immunotherapy-treated population).
No takes yet. Share an insight, caveat, or question.
Scalera et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: